OUR STAFF OF PRINCIPAL INVESTIGATORS INCLUDE: BOARD CERTIFIED DERMATOLOGIST, BOARD CERTIFIED FAMILY PRACTICE, BOARD CERTIFIED INTERNAL MEDICINE, BOARD CERTIFIED PSYCHIATRIST, BOARD CERTIFIED PEDIATRICIAN, ETC.
In 2012 Mr. Jose Fidalgo founded Floridian Research Institute, LLC. Floridian Research Institute, LLC is a Clinical Research Institution established in Florida, (USA).
During all these years our company has participated in different studies related to: Dermatology, Diabetes, Alzheimer’s Disease , Anemia, Asthma, COPD, Urinary Tract Infections, Influenza, Attention Deficit Hyperactivity Disorder, Contraceptives, Cystitis, Climacteric, Cold, Hernia, Herpes , HIV, Obesity, Papilloma virus Infections, Hysterotomy, Urologic Diseases, Constipation, Migraine, Urinary iIcontinence, Menopause, Condyloma, etc.
Our major advantage compared to other Clinical Research Institutions is that we have three locations in the cities of Miami (Florida), Fort Myers (Florida) and Homestead (Florida). This gives us the opportunity to have a broad database with people of different demographic characteristics such as races, ethnicities and ages among other things.
Our main objective in every investigation is to comply with all the requirements of the sponsors, taking in consideration that the purpose of conducting clinical investigations of a drug is to distinguish the effect of a drug from other influences, such as spontaneous change in the course of the disease, placebo effect or biased observation. Our Institution is very professional and committed to meet such standards.
Our staff is certified and has extensive experience in the Clinical Investigations and Research field.
*As part of our Staff we have Board Certified Doctors in different areas.
*We have a very high patient retention rate. Our constant communication and follow-up with our patients have proven to be an essential factor in the high rate of patient retention.
*Once a study is assigned to us, we develop different recruitment strategies to meet the number of patients that must be enrolled. Up to date we have been successful in meeting the number of patients assigned to us in each study.